AngioDynamics to Hold Fiscal Fourth Quarter and Full-Year 2008 Financial Results Conference Call on July 24, 2008

July 15, 2008 at 12:00 AM EDT
AngioDynamics to Hold Fiscal Fourth Quarter and Full-Year 2008 Financial Results Conference Call on July 24, 2008QUEENSBURY, N.Y., Jul 15, 2008 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal fourth quarter and full-year 2008 financial results on Thursday, July 24, 2008 after the close of the financial markets.

Eamonn P. Hobbs, president and chief executive officer, and Joseph Gersuk, executive vice president and CFO, will host an investment community conference call beginning at 4:30 p.m. Eastern time on July 24 to discuss these results and to answer questions.

To participate in the live call by telephone, please dial (800) 257-3401 from the U.S., or for international callers, please dial (303) 262-2131.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' website at http://investor.angiodynamics.com. To listen to the live call, please go to the website 15 minutes prior to its start to register, download, and install the necessary audio software.

A replay will be available on the website. A telephone replay will be available from 6:30 p.m. Eastern time on July 24, 2008 through 11:59 p.m. Eastern time on August 1 by dialing (800) 405-2236 (domestic) or (303) 590-3000 (international) and entering the passcode: 11117392#.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

SOURCE: AngioDynamics, Inc.

AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.


Investor Relations:
Doug Sherk, 415-896-6820
dsherk@evcgroup.com
Donald Takaya, 415-896-6820
dtakaya@evcgroup.com
or
Media:
Chris Gale, 646-201-5431
cgale@evcgroup.com